The Senate last night voted 92-2 to approve the conference report to the Comprehensive Addiction and Recovery Act (S. 524), legislation designed to help stem the epidemic of opioid abuse through education, prevention, treatment and rehabilitation. The bill incorporates several key AHA-endorsed measures, including the creation of a multi-agency task force with a hospital representative that will develop best practices for prescribing and pain management; more stringent pre-market review of new opioids by the Food and Drug Administration; increased access to opioid overdose reversal drugs and medication-assisted treatment; and expanded research and treatment for vulnerable populations. The House passed the conference report last week and President Obama is expected to sign it into law. AHA members today received a Special Bulletin with more on the legislation, as well as recent actions by the administration and AHA to combat the opioid abuse epidemic. 

Headline
The AHA is accepting applications through Aug. 18 for the 2027 Quest for Quality Prize, which recognizes hospitals and health systems that provide safe patient…
Headline
The Food and Drug Administration has identified a Class I recall of North American Rescue first aid kits containing TRUE METRIX Blood Glucose Monitoring…
Headline
The AHA’s American Organization for Nursing Leadership will host a biweekly virtual bootcamp from July 14-Aug. 25 for nurse executives and directors to provide…
Chairperson's File
Public
To improve the health of individuals and communities, hospitals and health systems provide holistic care to patients and work to address all factors that…
Headline
The Department of Health and Human Services June 26 announced new efforts to improve the Trusted Exchange Framework and Common Agreement. TEFCA is a common set…
Headline
Emergency department visits for suspected suicide attempts from 2021-2025 were highest among adolescents age 12-17 at 24.8%, according to a report released…